PT  - JOURNAL ARTICLE
AU  - S. Tajima
AU  - M. Bando
AU  - Y. Ishii
AU  - T. Hosono
AU  - H. Yamasawa
AU  - S. Ohno
AU  - T. Takada
AU  - E. Suzuki
AU  - F. Gejyo
AU  - Y. Sugiyama
TI  - Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice
AID  - 10.1183/09031936.00164407
DP  - 2008 Nov 01
TA  - European Respiratory Journal
PG  - 1337--1343
VI  - 32
IP  - 5
4099  - http://erj.ersjournals.com/content/32/5/1337.short
4100  - http://erj.ersjournals.com/content/32/5/1337.full
SO  - Eur Respir J2008 Nov 01; 32
AB  - Reactive oxygen species play an important role in the pathogenesis of acute lung injury and pulmonary fibrosis. The present authors hypothesise that edaravone, a free-radical scavenger, is able to attenuate bleomycin (BLM)-induced lung injury in mice by decreasing oxidative stress. Lung injury was induced in female ICR mice by intratracheal instillation of 5 mg·kg−1 of BLM. Edaravone (300 mg·kg−1) was administered by intraperitoneal administration 1 h before BLM challenge. Edaravone significantly improved the survival rate of mice treated with BLM from 25 to 90%, reduced the number of total cells and neutrophils in bronchoalveolar lavage fluid (BALF) on day 7, and attenuated the concentrations of lipid hydroperoxide in BALF and serum on day 2. The fibrotic change in the lung on day 28 was ameliorated by edaravone, as evaluated by histological examination and measurement of hydroxyproline contents. In addition, edaravone significantly increased the prostaglandin E2 concentration in BALF on day 2. In summary, edaravone was shown to inhibit lung injury and fibrosis via the repression of lipid hydroperoxide production and the elevation of prostaglandin E2 production in the present experimental murine system.